ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

In Brief: Contracts For Comparative NMR Imaging studies Awarded To Five Institutions; NCI Staff Honored

June 8, 1984

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Million Dollar Awards Pace Contracts Rush

July 4, 1975